CINXE.COM

InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Promising Long-Term Results for Alzheimer's Drug INM-901 - TinyGems

<!DOCTYPE html> <html lang="en-US" class="no-js"> <head> <!-- OneTrust Cookies Consent Notice start for tinygems.com --> <script src="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" type="text/javascript" charset="UTF-8" data-domain-script="0192e7ff-6cd0-7eeb-a526-454b4ec9d90f" ></script> <script type="text/javascript"> function OptanonWrapper() { } </script> <!-- OneTrust Cookies Consent Notice end for tinygems.com --> <meta charset="UTF-8"> <meta http-equiv="X-UA-Compatible" content="IE=edge"> <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=0"> <link rel="profile" href="http://gmpg.org/xfn/11"> <!-- Favicon and iOS bookmark --> <link rel="shortcut icon" href="https://tinygems.com/wp-content/themes/tinygems/favicon.ico" /> <meta property="og:image" content="https://tinygems.com/wp-content/themes/tinygems/fb-og-cnw.png" /> <link rel="stylesheet" href="https://tinygems.com/wp-content/themes/tinygems/css/angular-styles.css?1732408823" /> <link rel="stylesheet" href="https://tinygems.com/wp-content/themes/tinygems/js/fancyBox/source/jquery.fancybox.css" /> <link rel="apple-touch-icon-precomposed" href="https://tinygems.com/wp-content/themes/tinygems/ios-icon.png"/> <script src="https://ajax.googleapis.com/ajax/libs/angularjs/1.5.7/angular.min.js"></script> <script src="//ajax.googleapis.com/ajax/libs/angularjs/1.5.7/angular-animate.js"></script> <!-- TypeKit Web Fonts --> <link rel="stylesheet" href="https://use.typekit.net/xip4tqq.css"> <script>(function(html){html.className = html.className.replace(/\bno-js\b/,'js')})(document.documentElement);</script> <meta name='robots' content='index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1' /> <!-- This site is optimized with the Yoast SEO plugin v21.6 - https://yoast.com/wordpress/plugins/seo/ --> <title>InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Promising Long-Term Results for Alzheimer&#039;s Drug INM-901 - TinyGems</title> <link rel="canonical" href="https://tinygems.com/inmed-pharmaceuticals-inc-nasdaq-inm-reports-promising-long-term-results-for-alzheimers-drug-inm-901/" /> <meta property="og:locale" content="en_US" /> <meta property="og:type" content="article" /> <meta property="og:title" content="InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Promising Long-Term Results for Alzheimer&#039;s Drug INM-901 - TinyGems" /> <meta property="og:description" content="InMed Pharmaceuticals (NASDAQ: INM), a biopharmaceutical company focused on developing proprietary small molecule drug candidates for diseases with high unmet needs, has announced promising outcomes from a long-term preclinical study of its Alzheimer’s Disease (“AD”) drug candidate, INM-901. These new findings confirm and expand upon results from a previous short-term pilot study (https://ibn.fm/eASUI). The long-term &hellip; Continue reading &quot;InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Promising Long-Term Results for Alzheimer&#8217;s Drug INM-901&quot;" /> <meta property="og:url" content="https://tinygems.com/inmed-pharmaceuticals-inc-nasdaq-inm-reports-promising-long-term-results-for-alzheimers-drug-inm-901/" /> <meta property="og:site_name" content="TinyGems" /> <meta property="article:publisher" content="https://www.facebook.com/tinygems.com" /> <meta property="article:published_time" content="2024-08-26T13:00:00+00:00" /> <meta property="article:modified_time" content="2024-08-26T17:20:12+00:00" /> <meta name="author" content="Christian Amiscua" /> <meta name="twitter:card" content="summary_large_image" /> <meta name="twitter:creator" content="@tinygems" /> <meta name="twitter:site" content="@tinygems" /> <meta name="twitter:label1" content="Written by" /> <meta name="twitter:data1" content="Christian Amiscua" /> <meta name="twitter:label2" content="Est. reading time" /> <meta name="twitter:data2" content="4 minutes" /> <script type="application/ld+json" class="yoast-schema-graph">{"@context":"https://schema.org","@graph":[{"@type":"Article","@id":"https://tinygems.com/inmed-pharmaceuticals-inc-nasdaq-inm-reports-promising-long-term-results-for-alzheimers-drug-inm-901/#article","isPartOf":{"@id":"https://tinygems.com/inmed-pharmaceuticals-inc-nasdaq-inm-reports-promising-long-term-results-for-alzheimers-drug-inm-901/"},"author":{"name":"Christian Amiscua","@id":"https://tinygems.com/#/schema/person/d63601243e945851080e09e3984c0baa"},"headline":"InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Promising Long-Term Results for Alzheimer&#8217;s Drug INM-901","datePublished":"2024-08-26T13:00:00+00:00","dateModified":"2024-08-26T17:20:12+00:00","mainEntityOfPage":{"@id":"https://tinygems.com/inmed-pharmaceuticals-inc-nasdaq-inm-reports-promising-long-term-results-for-alzheimers-drug-inm-901/"},"wordCount":890,"publisher":{"@id":"https://tinygems.com/#organization"},"articleSection":["Tiny Gem"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https://tinygems.com/inmed-pharmaceuticals-inc-nasdaq-inm-reports-promising-long-term-results-for-alzheimers-drug-inm-901/","url":"https://tinygems.com/inmed-pharmaceuticals-inc-nasdaq-inm-reports-promising-long-term-results-for-alzheimers-drug-inm-901/","name":"InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Promising Long-Term Results for Alzheimer's Drug INM-901 - TinyGems","isPartOf":{"@id":"https://tinygems.com/#website"},"datePublished":"2024-08-26T13:00:00+00:00","dateModified":"2024-08-26T17:20:12+00:00","breadcrumb":{"@id":"https://tinygems.com/inmed-pharmaceuticals-inc-nasdaq-inm-reports-promising-long-term-results-for-alzheimers-drug-inm-901/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https://tinygems.com/inmed-pharmaceuticals-inc-nasdaq-inm-reports-promising-long-term-results-for-alzheimers-drug-inm-901/"]}]},{"@type":"BreadcrumbList","@id":"https://tinygems.com/inmed-pharmaceuticals-inc-nasdaq-inm-reports-promising-long-term-results-for-alzheimers-drug-inm-901/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://tinygems.com/"},{"@type":"ListItem","position":2,"name":"NewsRoom Articles","item":"https://tinygems.com/newsroom/newsroom-articles/"},{"@type":"ListItem","position":3,"name":"InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Promising Long-Term Results for Alzheimer&#8217;s Drug INM-901"}]},{"@type":"WebSite","@id":"https://tinygems.com/#website","url":"https://tinygems.com/","name":"TinyGems","description":"Spotlighting undiscovered companies with enormous upside potential.","publisher":{"@id":"https://tinygems.com/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https://tinygems.com/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https://tinygems.com/#organization","name":"TinyGems","url":"https://tinygems.com/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https://tinygems.com/#/schema/logo/image/","url":"https://tinygems.com/wp-content/uploads/tg-amp-logo.png","contentUrl":"https://tinygems.com/wp-content/uploads/tg-amp-logo.png","width":190,"height":142,"caption":"TinyGems"},"image":{"@id":"https://tinygems.com/#/schema/logo/image/"},"sameAs":["https://www.facebook.com/tinygems.com","https://twitter.com/tinygems"]},{"@type":"Person","@id":"https://tinygems.com/#/schema/person/d63601243e945851080e09e3984c0baa","name":"Christian Amiscua","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https://tinygems.com/#/schema/person/image/","url":"https://secure.gravatar.com/avatar/8a84f51d57cade327d2817ae67a6d290?s=96&d=mm&r=g","contentUrl":"https://secure.gravatar.com/avatar/8a84f51d57cade327d2817ae67a6d290?s=96&d=mm&r=g","caption":"Christian Amiscua"},"url":"https://tinygems.com/author/tg_ibn_christian/"}]}</script> <!-- / Yoast SEO plugin. --> <link rel="amphtml" href="https://tinygems.com/inmed-pharmaceuticals-inc-nasdaq-inm-reports-promising-long-term-results-for-alzheimers-drug-inm-901/amp/" /><meta name="generator" content="AMP for WP 1.0.98"/><link rel='dns-prefetch' href='//ajax.googleapis.com' /> <link rel='dns-prefetch' href='//cdnjs.cloudflare.com' /> <link rel='stylesheet' id='wp-block-library-css' href='https://tinygems.com/wp-includes/css/dist/block-library/style.min.css' type='text/css' media='all' /> <style id='classic-theme-styles-inline-css' type='text/css'> /*! This file is auto-generated */ .wp-block-button__link{color:#fff;background-color:#32373c;border-radius:9999px;box-shadow:none;text-decoration:none;padding:calc(.667em + 2px) calc(1.333em + 2px);font-size:1.125em}.wp-block-file__button{background:#32373c;color:#fff;text-decoration:none} </style> <style id='global-styles-inline-css' type='text/css'> body{--wp--preset--color--black: #000000;--wp--preset--color--cyan-bluish-gray: #abb8c3;--wp--preset--color--white: #ffffff;--wp--preset--color--pale-pink: #f78da7;--wp--preset--color--vivid-red: #cf2e2e;--wp--preset--color--luminous-vivid-orange: #ff6900;--wp--preset--color--luminous-vivid-amber: #fcb900;--wp--preset--color--light-green-cyan: #7bdcb5;--wp--preset--color--vivid-green-cyan: #00d084;--wp--preset--color--pale-cyan-blue: #8ed1fc;--wp--preset--color--vivid-cyan-blue: #0693e3;--wp--preset--color--vivid-purple: #9b51e0;--wp--preset--gradient--vivid-cyan-blue-to-vivid-purple: linear-gradient(135deg,rgba(6,147,227,1) 0%,rgb(155,81,224) 100%);--wp--preset--gradient--light-green-cyan-to-vivid-green-cyan: linear-gradient(135deg,rgb(122,220,180) 0%,rgb(0,208,130) 100%);--wp--preset--gradient--luminous-vivid-amber-to-luminous-vivid-orange: linear-gradient(135deg,rgba(252,185,0,1) 0%,rgba(255,105,0,1) 100%);--wp--preset--gradient--luminous-vivid-orange-to-vivid-red: linear-gradient(135deg,rgba(255,105,0,1) 0%,rgb(207,46,46) 100%);--wp--preset--gradient--very-light-gray-to-cyan-bluish-gray: linear-gradient(135deg,rgb(238,238,238) 0%,rgb(169,184,195) 100%);--wp--preset--gradient--cool-to-warm-spectrum: linear-gradient(135deg,rgb(74,234,220) 0%,rgb(151,120,209) 20%,rgb(207,42,186) 40%,rgb(238,44,130) 60%,rgb(251,105,98) 80%,rgb(254,248,76) 100%);--wp--preset--gradient--blush-light-purple: linear-gradient(135deg,rgb(255,206,236) 0%,rgb(152,150,240) 100%);--wp--preset--gradient--blush-bordeaux: linear-gradient(135deg,rgb(254,205,165) 0%,rgb(254,45,45) 50%,rgb(107,0,62) 100%);--wp--preset--gradient--luminous-dusk: linear-gradient(135deg,rgb(255,203,112) 0%,rgb(199,81,192) 50%,rgb(65,88,208) 100%);--wp--preset--gradient--pale-ocean: linear-gradient(135deg,rgb(255,245,203) 0%,rgb(182,227,212) 50%,rgb(51,167,181) 100%);--wp--preset--gradient--electric-grass: linear-gradient(135deg,rgb(202,248,128) 0%,rgb(113,206,126) 100%);--wp--preset--gradient--midnight: linear-gradient(135deg,rgb(2,3,129) 0%,rgb(40,116,252) 100%);--wp--preset--font-size--small: 13px;--wp--preset--font-size--medium: 20px;--wp--preset--font-size--large: 36px;--wp--preset--font-size--x-large: 42px;--wp--preset--spacing--20: 0.44rem;--wp--preset--spacing--30: 0.67rem;--wp--preset--spacing--40: 1rem;--wp--preset--spacing--50: 1.5rem;--wp--preset--spacing--60: 2.25rem;--wp--preset--spacing--70: 3.38rem;--wp--preset--spacing--80: 5.06rem;--wp--preset--shadow--natural: 6px 6px 9px rgba(0, 0, 0, 0.2);--wp--preset--shadow--deep: 12px 12px 50px rgba(0, 0, 0, 0.4);--wp--preset--shadow--sharp: 6px 6px 0px rgba(0, 0, 0, 0.2);--wp--preset--shadow--outlined: 6px 6px 0px -3px rgba(255, 255, 255, 1), 6px 6px rgba(0, 0, 0, 1);--wp--preset--shadow--crisp: 6px 6px 0px rgba(0, 0, 0, 1);}:where(.is-layout-flex){gap: 0.5em;}:where(.is-layout-grid){gap: 0.5em;}body .is-layout-flow > .alignleft{float: left;margin-inline-start: 0;margin-inline-end: 2em;}body .is-layout-flow > .alignright{float: right;margin-inline-start: 2em;margin-inline-end: 0;}body .is-layout-flow > .aligncenter{margin-left: auto !important;margin-right: auto !important;}body .is-layout-constrained > .alignleft{float: left;margin-inline-start: 0;margin-inline-end: 2em;}body .is-layout-constrained > .alignright{float: right;margin-inline-start: 2em;margin-inline-end: 0;}body .is-layout-constrained > .aligncenter{margin-left: auto !important;margin-right: auto !important;}body .is-layout-constrained > :where(:not(.alignleft):not(.alignright):not(.alignfull)){max-width: var(--wp--style--global--content-size);margin-left: auto !important;margin-right: auto !important;}body .is-layout-constrained > .alignwide{max-width: var(--wp--style--global--wide-size);}body .is-layout-flex{display: flex;}body .is-layout-flex{flex-wrap: wrap;align-items: center;}body .is-layout-flex > *{margin: 0;}body .is-layout-grid{display: grid;}body .is-layout-grid > *{margin: 0;}:where(.wp-block-columns.is-layout-flex){gap: 2em;}:where(.wp-block-columns.is-layout-grid){gap: 2em;}:where(.wp-block-post-template.is-layout-flex){gap: 1.25em;}:where(.wp-block-post-template.is-layout-grid){gap: 1.25em;}.has-black-color{color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-color{color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-color{color: var(--wp--preset--color--white) !important;}.has-pale-pink-color{color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-color{color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-color{color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-color{color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-color{color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-color{color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-color{color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-color{color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-color{color: var(--wp--preset--color--vivid-purple) !important;}.has-black-background-color{background-color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-background-color{background-color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-background-color{background-color: var(--wp--preset--color--white) !important;}.has-pale-pink-background-color{background-color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-background-color{background-color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-background-color{background-color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-background-color{background-color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-background-color{background-color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-background-color{background-color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-background-color{background-color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-background-color{background-color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-background-color{background-color: var(--wp--preset--color--vivid-purple) !important;}.has-black-border-color{border-color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-border-color{border-color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-border-color{border-color: var(--wp--preset--color--white) !important;}.has-pale-pink-border-color{border-color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-border-color{border-color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-border-color{border-color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-border-color{border-color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-border-color{border-color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-border-color{border-color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-border-color{border-color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-border-color{border-color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-border-color{border-color: var(--wp--preset--color--vivid-purple) !important;}.has-vivid-cyan-blue-to-vivid-purple-gradient-background{background: var(--wp--preset--gradient--vivid-cyan-blue-to-vivid-purple) !important;}.has-light-green-cyan-to-vivid-green-cyan-gradient-background{background: var(--wp--preset--gradient--light-green-cyan-to-vivid-green-cyan) !important;}.has-luminous-vivid-amber-to-luminous-vivid-orange-gradient-background{background: var(--wp--preset--gradient--luminous-vivid-amber-to-luminous-vivid-orange) !important;}.has-luminous-vivid-orange-to-vivid-red-gradient-background{background: var(--wp--preset--gradient--luminous-vivid-orange-to-vivid-red) !important;}.has-very-light-gray-to-cyan-bluish-gray-gradient-background{background: var(--wp--preset--gradient--very-light-gray-to-cyan-bluish-gray) !important;}.has-cool-to-warm-spectrum-gradient-background{background: var(--wp--preset--gradient--cool-to-warm-spectrum) !important;}.has-blush-light-purple-gradient-background{background: var(--wp--preset--gradient--blush-light-purple) !important;}.has-blush-bordeaux-gradient-background{background: var(--wp--preset--gradient--blush-bordeaux) !important;}.has-luminous-dusk-gradient-background{background: var(--wp--preset--gradient--luminous-dusk) !important;}.has-pale-ocean-gradient-background{background: var(--wp--preset--gradient--pale-ocean) !important;}.has-electric-grass-gradient-background{background: var(--wp--preset--gradient--electric-grass) !important;}.has-midnight-gradient-background{background: var(--wp--preset--gradient--midnight) !important;}.has-small-font-size{font-size: var(--wp--preset--font-size--small) !important;}.has-medium-font-size{font-size: var(--wp--preset--font-size--medium) !important;}.has-large-font-size{font-size: var(--wp--preset--font-size--large) !important;}.has-x-large-font-size{font-size: var(--wp--preset--font-size--x-large) !important;} .wp-block-navigation a:where(:not(.wp-element-button)){color: inherit;} :where(.wp-block-post-template.is-layout-flex){gap: 1.25em;}:where(.wp-block-post-template.is-layout-grid){gap: 1.25em;} :where(.wp-block-columns.is-layout-flex){gap: 2em;}:where(.wp-block-columns.is-layout-grid){gap: 2em;} .wp-block-pullquote{font-size: 1.5em;line-height: 1.6;} </style> <link rel='stylesheet' id='contact-form-7-css' href='https://tinygems.com/wp-content/plugins/contact-form-7/includes/css/styles.css' type='text/css' media='all' /> <link rel='stylesheet' id='genericons-css' href='https://tinygems.com/wp-content/themes/tinygems/genericons/genericons.css' type='text/css' media='all' /> <link rel='stylesheet' id='font-awesome-css' href='https://tinygems.com/wp-content/themes/tinygems/css/fontawesome-all.min.css' type='text/css' media='all' /> <link rel='stylesheet' id='tinygems-style-css' href='https://tinygems.com/wp-content/themes/tinygems/style.css' type='text/css' media='all' /> <link rel='stylesheet' id='customstyles-css' href='https://tinygems.com/wp-content/themes/tinygems/css/styles.css?1732408823' type='text/css' media='all' /> <link rel='stylesheet' id='tablepress-default-css' href='https://tinygems.com/wp-content/plugins/tablepress/css/build/default.css' type='text/css' media='all' /> <script type="text/javascript" src="https://tinygems.com/wp-includes/js/jquery/jquery.min.js" id="jquery-core-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-includes/js/jquery/jquery-migrate.min.js" id="jquery-migrate-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/fancyBox/source/jquery.fancybox.js" id="fancy-js"></script> <script type="text/javascript" src="//ajax.googleapis.com/ajax/libs/angularjs/1.5.7/angular-resource.js" id="ngresource-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/ng-lodash-master/build/ng-lodash.min.js" id="nglodash-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/moment.min.js" id="moment_min-js"></script> <script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/angular-moment/1.0.0-beta.6/angular-moment.min.js" id="ngmoment-js"></script> <!--[if lt IE 9]> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/html5.js" id="tinygems-html5-js"></script> <![endif]--> <link rel="https://api.w.org/" href="https://tinygems.com/wp-json/" /><link rel="alternate" type="application/json" href="https://tinygems.com/wp-json/wp/v2/posts/40194" /><link rel='shortlink' href='https://tinygems.com/?p=40194' /> <link rel="alternate" type="application/json+oembed" href="https://tinygems.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Ftinygems.com%2Finmed-pharmaceuticals-inc-nasdaq-inm-reports-promising-long-term-results-for-alzheimers-drug-inm-901%2F" /> <link rel="alternate" type="text/xml+oembed" href="https://tinygems.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Ftinygems.com%2Finmed-pharmaceuticals-inc-nasdaq-inm-reports-promising-long-term-results-for-alzheimers-drug-inm-901%2F&#038;format=xml" /> <!-- Global site tag (gtag.js) - Google Analytics --> <script async src="https://www.googletagmanager.com/gtag/js?id=G-X56RVJCEJS"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-X56RVJCEJS'); </script> <!-- Pearl Diver --> <script async src="https://tag.pearldiver.io/ldc.js?pid=7315ce62cb84c70d74b0564eb49eda9b&aid=16de03f2"></script> </head> <body class="post-template-default single single-post postid-40194 single-format-standard group-blog"> <!-- Announcement Bar --> <!-- Banner --> <div class="banner"> <div class="container"> <div class="logo"><a href="https://tinygems.com/"><img src="https://tinygems.com/wp-content/themes/tinygems/images/tinygems.png" alt="tinygems Logo"/></a></div> <div class="banner-right"> <h3>Spotlighting undiscovered companies with enormous upside potential.</h3> <div class="banner-right-flex"> <h4>Contact us: <span>(310) 299-1717</span></h4> <div class="social"> <ul> <li class="twitter"><a href="https://twitter.com/tinygems" target="_blank" rel="nofollow"></a></li> <li class="linkedin"><a href="https://www.linkedin.com/company/5133985?trk=tyah&trkInfo=tarId%3A1402372889813%2Ctas%3Atinygem%2Cidx%3A1-1-1" target="_blank" rel="nofollow"></a></li> <li class="facebook"><a href="https://www.facebook.com/tinygems.net" target="_blank" rel="nofollow"></a></li> </ul> </div></div> </div> <!-- Add hamburger to mobile --> <div id="hamburger"><span>Spotlighting undiscovered companies with enormous upside potential.</span></div><!-- End hamburger --> <div id="Menu"> <div class="menu-main-navigation-container"><ul id="menu-main-navigation" class="menu"><li id="menu-item-31636" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-home menu-item-31636"><a href="https://tinygems.com/">Home</a></li> <li id="menu-item-51" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-51"><a href="https://tinygems.com/about/">About</a></li> <li id="menu-item-5539" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-5539"><a href="https://tinygems.com/tiny-gems/">Tiny Gems</a></li> <li id="menu-item-17" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-17"><a href="https://tinygems.com/newsroom/">NewsRoom</a></li> <li id="menu-item-34478" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-34478"><a href="https://tinygems.com/newsletter-archives/">Newsletter Archives</a></li> <li id="menu-item-34872" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-34872"><a target="_blank" rel="noopener" href="https://www.investorbrandnetwork.com/events/">Events</a></li> <li id="menu-item-49" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-49"><a href="https://tinygems.com/contact/">Contact</a></li> </ul></div> </div> </div> </div> <!-- Headlines --> <div class="article-headlines"> <div class="container"> <div class="headlines-label"><a href="/newsroom/newsroom-articles/">Headlines</a></div> <div id="Headline"> <div class="cycle-slideshow" data-cycle-fx="scrollVert" data-cycle-timeout="5000" data-cycle-slides="> div"> <!-- wp:html --> <div> <a href="/gemxx-corp-gemz-announces-definitive-agreement-with-latin-energy-partners-in-strategic-latin-america-venture/">GEMXX Corp. (GEMZ) Announces Definitive Agreement with Latin Energy Partners in Strategic Latin America Venture</a> </div><div> <a href="/mullen-automotive-inc-nasdaq-muln-subsidiary-announces-first-dealership-deal-in-market-projected-to-see-record-sales/">Mullen Automotive Inc. (MULN) Subsidiary Announces First Dealership Deal in Market Projected to See Record Sales</a> </div><div> <a href="/lexaria-bioscience-corp-nasdaq-lexx-hires-new-ceo-amid-shift-in-focus-to-pharmaceutical-industry-collaboration-and-operations/">Lexaria Bioscience Corp. (LEXX) Hires New CEO in Focus to Pharmaceutical Industry Collaboration and Operations</a> </div><div> <a href="/inmed-pharmaceuticals-inc-s-nasdaq-inm-inm-901-a-promising-new-candidate-for-alzheimers-therapy/">InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-901: A Promising New Candidate for Alzheimer’s Therapy</a> </div><div> <a href="/clene-inc-nasdaq-clnn-presents-promising-preliminary-data-on-cnm-au8r-for-rett-syndrome-treatment/">Clene Inc. (CLNN) Presents Promising Preliminary Data on CNM-Au8(R) for Rett Syndrome Treatment</a> </div> <!-- /wp:html --> <!-- wp:paragraph --> <p></p> <!-- /wp:paragraph --> <!-- wp:paragraph --> <p></p> <!-- /wp:paragraph --> </div> </div> </div> </div> <div class="breadcrumb"><div class="container"><span><span><a href="https://tinygems.com/">Home</a></span> / <span><a href="https://tinygems.com/newsroom/newsroom-articles/">NewsRoom Articles</a></span> / <span class="breadcrumb_last" aria-current="page">InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Promising Long-Term Results for Alzheimer&#8217;s Drug INM-901</span></span></div></div> <!-- Content Area --> <div class="content"> <div class="container"> <article id="post-40194" class="post-40194 post type-post status-publish format-standard hentry category-tinygem"> <header class="entry-header"> <h1 class="entry-title">InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Promising Long-Term Results for Alzheimer&#8217;s Drug INM-901</h1> <p class="article-date">August 26, 2024</p> </header><!-- .entry-header --> <div class="ad-leader"></div> <div class="single-article-left"> <div class="entry-content"> <ul> <li>A long-term preclinical study of Alzheimer’s Disease (“AD”) drug candidate INM-901 included four groups: untreated disease-free, INM-901-treated disease-free, placebo-treated Alzheimer’s Disease, and INM-901-treated Alzheimer’s Disease at two dosing levels</li> <li>The results showed that INM-901-treated AD groups displayed behavior trends similar to the untreated disease-free group, with a clear dose response observed in most assessments</li> <li>The drug has also shown a reduction in neuroinflammation and enhancement of neuronal function, with molecular data supporting behavioral study observations</li> </ul> <p><a href="https://www.investorbrandnetwork.com/clients/inmed-pharmaceuticals-inc/" target="_blank" rel="noreferrer noopener">InMed Pharmaceuticals (NASDAQ: INM)</a>, a biopharmaceutical company focused on developing proprietary small molecule drug candidates for diseases with high unmet needs, has announced promising outcomes from a long-term preclinical study of its Alzheimer’s Disease (“AD”) drug candidate, INM-901. These new findings confirm and expand upon results from a previous short-term pilot study (<a href="https://ibn.fm/eASUI" target="_blank" rel="noreferrer noopener">https://ibn.fm/eASUI</a>).</p> <p>The long-term study, conducted over seven months, utilized the 5xFAD amyloidosis model, extending the dosing duration and increasing the sample size compared to the earlier three-month study. The study included four groups: untreated disease-free, INM-901-treated disease-free, placebo-treated Alzheimer’s Disease, and INM-901-treated Alzheimer’s Disease at two dosing levels. Given the progressive nature of the disease in this model, the groups in the long-term study exhibited more advanced AD than those in the short-term pilot.</p> <p>The study assessed several behavioral criteria across the four groups. Cognitive function and memory were evaluated using the Novel Object Recognition Test, while general locomotor activity was measured through the Open Field Test. Anxiety-related behavior was gauged using the Elevated and Zero Maze Tests, spatial learning and memory were assessed with the Barnes Maze Test, and sound awareness was tested with the Acoustic Startle Test.</p> <p>The results showed that INM-901-treated AD groups displayed behavior trends similar to the untreated disease-free group, with a clear dose response observed in most assessments. Significant improvements in specific behavioral criteria were noted compared to the placebo-treated AD groups, reinforcing and in some cases exceeding the outcomes of the short-term study.</p> <p>Dr. Eric Hsu, Senior Vice President of Preclinical Research and Development at InMed, expressed optimism about the findings. “We are highly encouraged by the initial data from this long-term study, which supports the improvements in behavioral outcomes observed in our initial short-term preclinical Alzheimer’s proof-of-concept study. INM-901 continues to show potential by targeting multiple biological pathways associated with Alzheimer’s Disease, addressing the critical need for effective treatments,” Dr. Hsu added.</p> <p>To better understand the mechanisms of action and the potential role of INM-901 in AD treatment, InMed is conducting further molecular analyses. These analyses will focus on receptor engagement (CB1/CB2 and PPAR), neuroinflammation (levels of various cytokines and inflammatory marker proteins), neurogenesis (markers for neuronal differentiation and function), and neuroprotection (evaluating stress responses and cellular growth/survival).</p> <p>In addition to these analyses, the development of the chemistry, manufacturing, and controls (“CMC”) for both the drug substance and product formulation is ongoing. GLP studies are in the planning stages to support an IND submission.</p> <p>Research and development activities to date have demonstrated that INM-901 targets several biological pathways associated with AD, exhibiting positive pharmacological characteristics. These include preferential signaling agonism for CB1/CB2 and impacts on PPAR signaling pathways, blood/brain barrier penetration with potential for oral administration, neuroprotective effects against amyloid-beta-induced cytotoxicity, and promotion of neurite outgrowth, indicating potential improvement in neuronal function.</p> <p>The drug has also shown a reduction in neuroinflammation and enhancement of neuronal function, with molecular data supporting behavioral study observations. InMed Pharmaceuticals continues to advance its research on INM-901, aiming to address the urgent need for effective Alzheimer’s treatments.</p> <p>For more information, visit the company’s website at&nbsp;<a href="http://www.inmedpharma.com/" target="_blank" rel="noreferrer noopener">www.InMedPharma.com</a>.</p> <p><strong>NOTE TO INVESTORS:</strong>&nbsp;The latest news and updates relating to INM are available in the company’s newsroom at&nbsp;<a href="https://ibn.fm/INM" target="_blank" rel="noreferrer noopener">https://ibn.fm/INM</a></p> <p><strong>About TinyGems</strong></p> <p><a href="https://tinygems.com/" target="_blank" rel="noreferrer noopener">TinyGems</a> is a specialized communications platform with a focus on innovative small-cap and mid-cap companies with bright futures and huge potential. It is one of 60+ brands within&nbsp;the <a href="https://www.investorbrandnetwork.com/dynamic-brand-portfolio/" target="_blank" rel="noreferrer noopener"><strong>Dynamic Brand Portfolio</strong></a> @ <a href="https://www.investorbrandnetwork.com/" target="_blank" rel="noreferrer noopener"><strong>IBN</strong></a> that delivers<strong>:</strong>&nbsp;(1) access to a vast network of wire solutions via&nbsp;<a href="https://www.investorwire.com/" target="_blank" rel="noreferrer noopener">InvestorWire</a>&nbsp;to efficiently and effectively reach a myriad of target markets, demographics and diverse industries<strong>;</strong>&nbsp;(2) article and <a href="https://www.investorbrandnetwork.com/solutions/press-distribution-via-investorwire/syndication-partners/" target="_blank" rel="noreferrer noopener">editorial syndication to 5,000+ outlets</a><strong>;</strong>&nbsp;(3) enhanced <a href="https://www.investorwire.com/investorwire-press-distribution/press-release-enhancement/" target="_blank" rel="noreferrer noopener">press release enhancement</a> to ensure maximum impact<strong>;</strong> (4) <a href="https://www.investorbrandnetwork.com/social-media-network/" target="_blank" rel="noreferrer noopener">social media distribution</a> via IBN to millions of social media followers<strong>;</strong>&nbsp;and (5) a full array of tailored <a href="https://www.investorbrandnetwork.com/solutions/" target="_blank" rel="noreferrer noopener">corporate communications solutions</a>. With broad reach and a seasoned team of contributing journalists and writers, TinyGems is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, TinyGems brings its clients unparalleled recognition and brand awareness. TinyGems is where breaking news, insightful content and actionable information converge.</p> <p><strong>To receive SMS alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only)</strong></p> <p>For more information, please visit <a href="https://tinygems.com/" target="_blank" rel="noreferrer noopener">https://www.TinyGems.com</a></p> <p>Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: <a href="https://tinygems.com/Disclaimer" target="_blank" rel="noreferrer noopener">https://www.TinyGems.com/Disclaimer</a></p> <p>TinyGems<br>Los Angeles, CA<br><a href="https://tinygems.com/" target="_blank" rel="noreferrer noopener">www.TinyGems.com</a><br>310.299.1717 Office<br><a href="mailto:Editor@TinyGems.com" target="_blank" rel="noreferrer noopener">Editor@TinyGems.com</a></p> <p>TinyGems is powered by <a href="https://www.investorbrandnetwork.com/" target="_blank" rel="noreferrer noopener">IBN</a></p> </div><!-- entry-content --> <nav class="navigation post-navigation" aria-label="Posts"> <h2 class="screen-reader-text">Post navigation</h2> <div class="nav-links"><div class="nav-previous"><a href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-targeting-oral-glp-1-alternatives-for-diabetes-and-obesity-treatment/" rel="prev"><span class="meta-nav" aria-hidden="true">Previous</span> <span class="screen-reader-text">Previous post:</span> <span class="post-title">Lexaria Bioscience Corp. (NASDAQ: LEXX) Targeting Oral GLP-1 Alternatives for Diabetes and Obesity Treatment</span></a></div><div class="nav-next"><a href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-validates-technologys-superiority-moving-closer-to-a-share-in-the-global-diabetes-treatment-market/" rel="next"><span class="meta-nav" aria-hidden="true">Next</span> <span class="screen-reader-text">Next post:</span> <span class="post-title">Lexaria Bioscience Corp. (NASDAQ: LEXX) Validates Technology’s Superiority, Moving Closer to a Share in the Global Diabetes Treatment Market</span></a></div></div> </nav> </div> <div class="single-article-right"> <div class="ad-sidebar"></div> <aside id="secondary" class="sidebar widget-area" role="complementary"> <section id="recent-posts-2" class="widget widget_recent_entries"> <h2 class="widget-title">Recent Articles</h2> <ul> <li> <a href="https://tinygems.com/calidi-biotherapeutics-inc-nyse-american-cldi-shares-data-supporting-innovative-proprietary-systemic-antitumor-platform/">Calidi Biotherapeutics Inc. (NYSE American: CLDI) Shares Data Supporting Innovative Proprietary Systemic Antitumor Platform</a> </li> <li> <a href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-hires-new-ceo-amid-shift-in-focus-to-pharmaceutical-industry-collaboration-and-operations/">Lexaria Bioscience Corp. (NASDAQ: LEXX) Hires New CEO Amid Shift in Focus to Pharmaceutical Industry Collaboration and Operations</a> </li> <li> <a href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-demonstrates-continued-dehydratechtm-liraglutide-performance-with-ongoing-glp-1-diabetes-animal-study/">Lexaria Bioscience Corp. (NASDAQ: LEXX) Demonstrates Continued DehydraTECH(TM)-Liraglutide Performance with Ongoing GLP-1 Diabetes Animal Study</a> </li> <li> <a href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-yields-extremely-interesting-results-for-dehydratechtm-liraglutide-in-ongoing-diabetes-animal-study/">Lexaria Bioscience Corp. (NASDAQ: LEXX) Yields “Extremely Interesting” Results for DehydraTECH(TM) Liraglutide in Ongoing Diabetes Animal Study</a> </li> <li> <a href="https://tinygems.com/inmed-pharmaceuticals-inc-s-nasdaq-inm-inm-901-a-promising-new-candidate-for-alzheimers-therapy/">InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-901: A Promising New Candidate for Alzheimer’s Therapy</a> </li> <li> <a href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-validates-technologys-superiority-moving-closer-to-a-share-in-the-global-diabetes-treatment-market/">Lexaria Bioscience Corp. (NASDAQ: LEXX) Validates Technology’s Superiority, Moving Closer to a Share in the Global Diabetes Treatment Market</a> </li> <li> <a href="https://tinygems.com/inmed-pharmaceuticals-inc-nasdaq-inm-reports-promising-long-term-results-for-alzheimers-drug-inm-901/" aria-current="page">InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Promising Long-Term Results for Alzheimer&#8217;s Drug INM-901</a> </li> <li> <a href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-targeting-oral-glp-1-alternatives-for-diabetes-and-obesity-treatment/">Lexaria Bioscience Corp. (NASDAQ: LEXX) Targeting Oral GLP-1 Alternatives for Diabetes and Obesity Treatment</a> </li> <li> <a href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-releases-q3-2024-financial-results-offers-a-roadmap-for-its-key-glp-1-study-program/">Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Q3 2024 Financial Results; Offers a Roadmap for its Key GLP-1 Study Program</a> </li> <li> <a href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-exploring-alternative-diabetes-and-obesity-treatments/">Lexaria Bioscience Corp. (NASDAQ: LEXX) Exploring Alternative Diabetes and Obesity Treatments</a> </li> </ul> </section> </aside><!-- .sidebar .widget-area --> <h2>Archives</h2> <div class="selectamonth">Select A Month</div> <div class="sam-outer-container"> <div class="sam-inner-container"> <div class="sam-panel"> <li><a href='https://tinygems.com/2024/11/'>November 2024</a></li> <li><a href='https://tinygems.com/2024/09/'>September 2024</a></li> <li><a href='https://tinygems.com/2024/08/'>August 2024</a></li> <li><a href='https://tinygems.com/2024/07/'>July 2024</a></li> <li><a href='https://tinygems.com/2024/06/'>June 2024</a></li> <li><a href='https://tinygems.com/2024/05/'>May 2024</a></li> <li><a href='https://tinygems.com/2024/04/'>April 2024</a></li> <li><a href='https://tinygems.com/2024/03/'>March 2024</a></li> <li><a href='https://tinygems.com/2024/02/'>February 2024</a></li> <li><a href='https://tinygems.com/2024/01/'>January 2024</a></li> <li><a href='https://tinygems.com/2023/12/'>December 2023</a></li> <li><a href='https://tinygems.com/2023/11/'>November 2023</a></li> <li><a href='https://tinygems.com/2023/10/'>October 2023</a></li> <li><a href='https://tinygems.com/2023/09/'>September 2023</a></li> <li><a href='https://tinygems.com/2023/08/'>August 2023</a></li> <li><a href='https://tinygems.com/2023/07/'>July 2023</a></li> <li><a href='https://tinygems.com/2023/06/'>June 2023</a></li> <li><a href='https://tinygems.com/2023/05/'>May 2023</a></li> <li><a href='https://tinygems.com/2023/04/'>April 2023</a></li> <li><a href='https://tinygems.com/2023/03/'>March 2023</a></li> <li><a href='https://tinygems.com/2023/02/'>February 2023</a></li> <li><a href='https://tinygems.com/2023/01/'>January 2023</a></li> <li><a href='https://tinygems.com/2022/12/'>December 2022</a></li> <li><a href='https://tinygems.com/2022/11/'>November 2022</a></li> <li><a href='https://tinygems.com/2022/10/'>October 2022</a></li> <li><a href='https://tinygems.com/2022/09/'>September 2022</a></li> <li><a href='https://tinygems.com/2022/08/'>August 2022</a></li> <li><a href='https://tinygems.com/2022/07/'>July 2022</a></li> <li><a href='https://tinygems.com/2022/06/'>June 2022</a></li> <li><a href='https://tinygems.com/2022/05/'>May 2022</a></li> </div> </div> </div> </div> </article><!-- #post-## --> </div> </div> <!-- Conference Logos --> <!-- Red Message Panel --> <div class="red-panel"> <div class="container"> <p>Contact us: <span>(310) 299-1717</span></p> </div> </div> <!-- Footer --> <div class="footer"> <div class="container"> <div class="quarter"> <a href="https://tinygems.com/"><img src="https://tinygems.com/wp-content/themes/tinygems/images/tinygems-white.png" alt="TinyGems" title="TinyGems"/></a> <h6><a href="https://tinygems.com/">TinyGems</a></h6> <p>8033 Sunset Blvd. Suite TG-1037 <br/>Los Angeles, CA 90046 <br/>(310) 299-1717</p> <ul class="social"> <li class="twitter"><a href="https://twitter.com/tinygems" target="_blank" rel="nofollow"></a></li> <li class="linkedin"><a href="https://www.linkedin.com/company/5133985?trk=tyah&trkInfo=tarId%3A1402372889813%2Ctas%3Atinygem%2Cidx%3A1-1-1" target="_blank" rel="nofollow"></a></li> <li class="facebook"><a href="https://www.facebook.com/tinygems.net" target="_blank" rel="nofollow"></a></li> </ul> </div> <div class="quarter"> <div class="menu-footer-solutions-container"><ul id="menu-footer-solutions" class="menu"><li id="menu-item-31334" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-31334"><a href="https://tinygems.com/tiny-gems/">Tiny Gems</a></li> <li id="menu-item-33891" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-33891"><a href="https://tinygems.com/newsroom/">NewsRoom</a></li> <li id="menu-item-34479" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-34479"><a href="https://tinygems.com/newsletter-archives/">Newsletter Archives</a></li> <li id="menu-item-34873" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-34873"><a target="_blank" rel="noopener" href="https://www.investorbrandnetwork.com/events/">Events</a></li> </ul></div> </div> <div class="quarter"> <div class="menu-footer-other-container"><ul id="menu-footer-other" class="menu"><li id="menu-item-34480" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-34480"><a href="https://tinygems.com/about/">About</a></li> <li id="menu-item-34481" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-privacy-policy menu-item-34481"><a rel="privacy-policy" href="https://tinygems.com/disclaimer/">Disclaimer</a></li> <li id="menu-item-34482" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-34482"><a href="https://tinygems.com/contact/">Contact</a></li> </ul></div> </div> <div class="quarter"> <div class="quickquote"> <h6>Quote / Research</h6> <input type="text" id="SymbolField" placeholder="Enter Symbol"> <a href="" class="getQuote">Get Quote</a> <h6 class="sitesearch">Site Search</h6> <form role="search" method="get" class="search-form" action="https://tinygems.com/"> <input type="search" class="search-field" placeholder="Search Term &hellip;" value="" name="s" /> <button type="submit" class="search-submit">Search</button> </form> </div> </div> <div class="copyright"> <p>Copyright &copy; <script language="JavaScript" type="text/javascript"> var d=new Date(); yr=d.getFullYear(); if (yr!=2020) document.write("2020 - "+yr); else {document.write(""+yr);} </script>. TinyGems / 8033 Sunset Blvd. Suite TG-1037, Los Angeles, CA 90046 (310) 299-1717 / <a href="/disclaimer">Disclaimers</a></p> <p class="captcha-statement">Forms are protected by reCAPTCHA and the Google <a href="https://policies.google.com/privacy" target="_blank" rel="noopener noreferrer">Privacy Policy</a> and <a href="https://policies.google.com/terms" target="_blank" rel="noopener noreferrer">Terms of Service</a> apply.</p> </div> </div> </div> <!--Start of Tawk.to Script (0.7.2)--> <script id="tawk-script" type="text/javascript"> var Tawk_API = Tawk_API || {}; var Tawk_LoadStart=new Date(); (function(){ var s1 = document.createElement( 'script' ),s0=document.getElementsByTagName( 'script' )[0]; s1.async = true; s1.src = 'https://embed.tawk.to/6310b06854f06e12d8922d61/1gbsj268n'; s1.charset = 'UTF-8'; s1.setAttribute( 'crossorigin','*' ); s0.parentNode.insertBefore( s1, s0 ); })(); </script> <!--End of Tawk.to Script (0.7.2)--> <script type="text/javascript" id="ges_angular_script-js-extra"> /* <![CDATA[ */ var wp_data = {"ajaxurl":"https:\/\/tinygems.com\/wp-admin\/admin-ajax.php","symbol":null}; /* ]]> */ </script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/ang-script.js?1732408823" id="ges_angular_script-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/plugins/contact-form-7/includes/swv/js/index.js" id="swv-js"></script> <script type="text/javascript" id="contact-form-7-js-extra"> /* <![CDATA[ */ var wpcf7 = {"api":{"root":"https:\/\/tinygems.com\/wp-json\/","namespace":"contact-form-7\/v1"}}; /* ]]> */ </script> <script type="text/javascript" src="https://tinygems.com/wp-content/plugins/contact-form-7/includes/js/index.js" id="contact-form-7-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/skip-link-focus-fix.js" id="tinygems-skip-link-focus-fix-js"></script> <script type="text/javascript" id="tinygems-script-js-extra"> /* <![CDATA[ */ var screenReaderText = {"expand":"expand child menu","collapse":"collapse child menu"}; /* ]]> */ </script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/functions.js" id="tinygems-script-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/js.cookie.min.js" id="tinygems-cookies-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/custom.js" id="tinygems-myscripts-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/jquery.cycle2.min.js" id="tinygems-cycle-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/jquery.cycle2.scrollVert.min.js" id="tinygems-cycle-vert-js"></script> <script type="text/javascript" src="https://www.google.com/recaptcha/api.js?render=6LdoYukfAAAAANjIa2I8Gxc0Ty_xdMITmbwMhOmA" id="google-recaptcha-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-includes/js/dist/vendor/wp-polyfill-inert.min.js" id="wp-polyfill-inert-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-includes/js/dist/vendor/regenerator-runtime.min.js" id="regenerator-runtime-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-includes/js/dist/vendor/wp-polyfill.min.js" id="wp-polyfill-js"></script> <script type="text/javascript" id="wpcf7-recaptcha-js-extra"> /* <![CDATA[ */ var wpcf7_recaptcha = {"sitekey":"6LdoYukfAAAAANjIa2I8Gxc0Ty_xdMITmbwMhOmA","actions":{"homepage":"homepage","contactform":"contactform"}}; /* ]]> */ </script> <script type="text/javascript" src="https://tinygems.com/wp-content/plugins/contact-form-7/modules/recaptcha/index.js" id="wpcf7-recaptcha-js"></script> </body> </html>

Pages: 1 2 3 4 5 6 7 8 9 10